Long-term response with the atypical reaction to nivolumab in microsatellite stability metastatic colorectal cancer: A case report

Long-term response with the atypical reaction to nivolumab in microsatellite stability metastatic colorectal cancer: A case report

Immunotherapy has become an integral part of a comprehensive treatment approach to metastatic colorectal cancer (mCRC). Nivolumab (Opdivo) is a human immunoglobulin G4 monoclonal antibody that blocks the interaction between the programmed cell death 1 (PD-1) receptor and its ligands 1/2 (PD-L1/PD-L2...

Full description

Bibliographic Details
Main Authors: Nataliya Babyshkina, Nataliya Popova, Evgeny Grigoryev, Tatyana Dronova, Polina Gervas, Alexey Dobrodeev, Dmitry Kostromitskiy, Victor Goldberg, Sergei Afanasiev, Nadejda Cherdyntseva
Format: Article
Language:English
Published: AboutScience Srl 2024-01-01
Series:Drug Target Insights
Subjects:
Dissociated response
iRECIST
Metastatic colorectal cancer
Microsatellite stability
Nivolumab
Online Access:https://journals.aboutscience.eu/index.php/dti/article/view/2637

Internet

https://journals.aboutscience.eu/index.php/dti/article/view/2637

Similar Items